Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
Lowe, Natalie M Bernstein, Jonathan M Mais, Kathleen L Garcez, Kate Lee, Lip W Sykes, Andrew J Thomson, David J Homer, Jarrod J
Lowe, Natalie M
Bernstein, Jonathan M
Mais, Kathleen L
Garcez, Kate
Lee, Lip W
Sykes, Andrew J
Thomson, David J
Homer, Jarrod J
Citations
Altmetric:
Abstract
The benefit of adding docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy to chemoradiotherapy (CRT) in head and neck squamous cell carcinoma (HNSCC) remains uncertain. We aimed to investigate whether ICT is well tolerated when given with prophylactic treatment against predicted adverse effects and which patients benefit most.
Description
Date
2017-12-08
Publisher
Collections
Keywords
Type
Article
Citation
Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status. 2017, J Cancer Res Clin Oncol